<div id="readability-page-1"><div> <div> , /PRNewswire/ -- Vitrolife AB (publ) will publish its Q1 2026 interim report on Thursday, 23 April 2026 at 08:00 am CET. A conference call for investors, analysts and financial media will be held at 10:00 am CET the same day. The presentation will be held in English by Bronwyn Brophy O'Connor, CEO, and Pär Ihrskog, CFO. The conference call will begin with a presentation of the report followed by a question-and-answer session. The presentation material will be available prior to the start of the conference call on the Vitrolife Group website www.vitrolifegroup.com. To follow the webcast, please use this link. To participate in the conference call please register via this link. After registration, you will be provided with telephone numbers and a conference ID to access the conference. You can ask questions verbally via the telephone conference. After the event, the presentation material and a recording of the webcast will be available at www.vitrolifegroup.com. Gothenburg, 9 April 2026 VITROLIFE AB (publ) Contact: Jenny Jakobson Investor Relations [email protected] This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails. This information was brought to you by Cision http://news.cision.com https://news.cision.com/vitrolife-ab--publ-/r/invitation-to-vitrolife-group-s-presentation-of-the-q1-2026-interim-report,c4331301 SOURCE Vitrolife AB (publ) <img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNDA5Jk5ld3NJdGVtSWQ9Q0czMDU0NSZUcmFuc21pc3Npb25fSWQ9MjAyNjA0MDkwMzI5UFJfTkVXU19VU1BSX19fX19DRzMwNTQ1?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNDA5Jk5ld3NJdGVtSWQ9Q0czMDU0NSZUcmFuc21pc3Npb25fSWQ9MjAyNjA0MDkwMzI5UFJfTkVXU19VU1BSX19fX19DRzMwNTQ1"/></div> </div></div>

SBIO

IBBQ

LABU

Vitrolife AB (publ) will release its Q1 2026 interim report on April 23, 2026, at 08:00 am CET. A conference call for investors and analysts will follow at 10:00 am CET, featuring CEO Bronwyn Brophy O'Connor and CFO Pär Ihrskog. The presentation will be in English, with a Q&A session afterward. Presentation materials will be available on the Vitrolife Group website prior to the call. Registration is required to participate in the conference call.

prnewswire

ALPS Medical Breakthrough

Invesco Nasdaq Biotechnology ETF

First Trust NYSE Arca Biotech Index Fd

Direxion S&P Biotech Bull 3X

Invesco Biotechnology & Genome ETF

Proshares UltraShort Nasdaq Biotech

VanEck Biotech ETF

iShares Biotechnology ETF

Proshares Ultra Nasdaq Biotech

SPDR S&P Biotech

03:29 ETInvitation to Vitrolife Group's presentation of the Q1 2026 interim report